totum-63
Botanicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02868177)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- totum-63
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05369585 | N/A | Apr 25, 2022 | Laval University, Valbiotis |
| NCT04423302 | N/A | Jul 31, 2020 | Pasteur Merieux, Valbiotis |
| NCT02868177 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2016 | Biofortis, Institut Pasteur, UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France, Valbiotis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Valbiotis | For profit | 3 | 3 | 2 | 2016 |
| Biofortis | For profit | 1 | 0 | 1 | 2016 |
| Institut Pasteur | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Laval University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Pasteur Merieux | For profit | 1 | 0 | 1 | 2020 |
| UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France | Academic/Hospital | 1 | 0 | 1 | 2016 |
6 organizations
Page 1 / 1